Royal Harbor Partners, LLC Pfizer Inc Transaction History

Royal Harbor Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 05, 2022	BUY	$45.75 - $56.69 $1,830 - $2,267	40 Added 0.49%	8,245 $427,000
Q1 2021 Apr 12, 2021	SELL	$33.49 - $37.77 $15,706 - $17,714	-469 Reduced 5.41%	8,205 $297,000
Q1 2020 Apr 10, 2020	BUY	$27.03 - $38.62 $7,622 - $10,890	282 Added 3.36%	8,674 $283,000
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $276,264 - $313,525	8,392 New	8,392 $329,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Harbor Partners, LLC with notifications on news.